Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance.

Leeha, Marisa; Kanokwiroon, Kanyanatt; Laohawiriyakamol, Suphawat; Thongsuksai, Paramee

Leeha, Marisa; Kanokwiroon, Kanyanatt; Laohawiriyakamol, Suphawat; Thongsuksai, Paramee.

Afiliación

Leeha M; Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Kanokwiroon K; Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Laohawiriyakamol S; Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Thongsuksai P; Department of Pathology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

Pathol Oncol Res ; 29: 1611162, 2023.

Article en En | MEDLINE | ID: mdl-37274773

Asunto(s)

Neoplasias de la Mama; Neoplasias de la Mama Triple Negativas; Humanos; Femenino; Pronóstico; Neoplasias de la Mama Triple Negativas/patología; Receptores Androgénicos; Inmunohistoquímica; Biomarcadores de Tumor

Palabras clave

breast cancer; immunohistochemistry; molecular subtype; prognosis; triple-negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Prognostic_studies Idioma: En Revista: Pathol Oncol Res Asunto de la revista: NEOPLASIAS / PATOLOGIA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google